Detailed explanation of precautions when using tenofovir alafenamide tablets (Vemlidy)

Tenofovir alafenamide tablets (Vemlidy/Vemlidy) is an antiviral drug for the treatment of hepatitis B. Special attention should be paid to some safety matters during use to ensure the efficacy of the drug and the safety of the patient. Patients should fully understand its indications, contraindications and possible adverse reactions before using this drug.

First of all, tenofovir alafenamide fumarate tablets are nucleotide reverse transcriptase inhibitors and are mainly used to treat hepatitis B virus infection, especially for patients with compensated liver disease whose liver function is relatively stable. During the use of the drug, liver function and viral load must be monitored regularly to evaluate the effectiveness of the treatment. In addition, patients with abnormal liver function should be cautious when using this drug and adjust the treatment plan under the guidance of a doctor.

Secondly, tenofovir alafenamide fumarate tablets may cause kidney-related adverse reactions. Therefore, during treatment, especially patients with a history of renal impairment, renal function should be monitored regularly. If abnormal kidney function is found, your doctor may consider adjusting the dose or discontinuing the drug to reduce the risk of kidney damage.

Because this drug is excreted by the kidneys, use special caution in patients with poor renal function. Especially in elderly patients, renal function may be reduced, so dosage needs to be adjusted on a case-by-case basis. In addition, tenofovir alafenamide fumarate tablets may also cause a decrease in bone density. Therefore, during long-term treatment, bone density needs to be checked regularly, especially for patients at risk of osteoporosis.

At the same time, tenofovir alafenamide fumarate tablets are not suitable for patients with acute hepatitis B or decompensated liver function. Before using this medicine, patients should ensure that they undergo a comprehensive physical examination and receive treatment under the advice of their doctor.

Reference materials:https://www.drugs.com/vemlidy.html